-
公开(公告)号:USRE39197E1
公开(公告)日:2006-07-18
申请号:US10356794
申请日:2002-08-29
申请人: James T. Link , Gang Liu , Zhonghua Pei , Tom von Geldern , Martin Winn , Zhili Xin
发明人: James T. Link , Gang Liu , Zhonghua Pei , Tom von Geldern , Martin Winn , Zhili Xin
IPC分类号: A61K31/505 , A61K31/405 , C07D239/70 , C07D319/14 , C07D319/00
CPC分类号: C07D207/27 , C07C323/62 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D207/09 , C07D207/14 , C07D207/20 , C07D207/22 , C07D207/26 , C07D209/08 , C07D209/18 , C07D211/22 , C07D211/26 , C07D211/42 , C07D211/46 , C07D211/54 , C07D211/60 , C07D211/62 , C07D211/74 , C07D213/74 , C07D213/75 , C07D213/81 , C07D215/36 , C07D217/06 , C07D235/26 , C07D239/42 , C07D241/04 , C07D241/24 , C07D243/08 , C07D265/30 , C07D295/13 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D295/32 , C07D307/52 , C07D307/68 , C07D317/58 , C07D317/62 , C07D319/18 , C07D319/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D471/10 , C07D487/08 , C07D491/10
摘要: The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
-
2.Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds 失效
标题翻译: 细胞粘附抑制抗炎和免疫抑制化合物公开(公告)号:US06878700B1
公开(公告)日:2005-04-12
申请号:US09541795
申请日:2000-03-31
申请人: James Link , Gang Liu , ZhongHua Pei , Tom von Geldern , Martin Winn , Zhili Xin , Steven A. Boyd , Gui-Dong Zhu , Jennifer C. Freeman , Indrani W. Gunawardana , Michael A. Staeger , Hwan-Soo Jae , John K. Lynch , Sheldon Wang
发明人: James Link , Gang Liu , ZhongHua Pei , Tom von Geldern , Martin Winn , Zhili Xin , Steven A. Boyd , Gui-Dong Zhu , Jennifer C. Freeman , Indrani W. Gunawardana , Michael A. Staeger , Hwan-Soo Jae , John K. Lynch , Sheldon Wang
IPC分类号: A61K31/454 , A61K31/495 , A61K31/496 , A61K31/537 , A61K31/54 , C07C323/62 , C07D205/04 , C07D207/09 , C07D207/14 , C07D207/26 , C07D207/27 , C07D209/08 , C07D211/20 , C07D211/46 , C07D211/60 , C07D213/40 , C07D213/81 , C07D217/06 , C07D241/04 , C07D295/185 , C07D295/26 , C07D401/04 , C07D521/00 , A61K31/33 , A61K31/415 , C07D221/02 , C07D265/30 , C07D319/00
CPC分类号: C07D207/27 , A61K31/454 , A61K31/495 , A61K31/496 , A61K31/537 , A61K31/54 , C07C323/62 , C07C2601/02 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/08 , C07D211/20 , C07D211/46 , C07D211/60 , C07D213/40 , C07D213/81 , C07D217/06 , C07D231/12 , C07D233/56 , C07D241/04 , C07D249/08 , C07D295/185 , C07D295/26 , C07D401/04
摘要: The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immunune diseases, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
摘要翻译: 本发明涉及可用于治疗炎性和免疫疾病的新型肉桂酰胺化合物,含有这些化合物的药物组合物,以及抑制哺乳动物炎症或抑制免疫应答的方法。
-
3.Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds 有权
标题翻译: 细胞粘附抑制抗炎和免疫抑制化合物公开(公告)号:US6110922A
公开(公告)日:2000-08-29
申请号:US222491
申请日:1998-12-29
申请人: James Link , Gang Liu , Zhonghua Pei , Tom von Geldern , Martin Winn , Zhili Xin
发明人: James Link , Gang Liu , Zhonghua Pei , Tom von Geldern , Martin Winn , Zhili Xin
IPC分类号: C07D295/12 , A61K31/16 , A61K31/164 , A61K31/165 , A61K31/167 , A61K31/40 , A61K31/4015 , A61K31/404 , A61K31/407 , A61K31/417 , A61K31/438 , A61K31/44 , A61K31/443 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/45 , A61K31/453 , A61K31/454 , A61K31/472 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/541 , A61P29/00 , A61P37/02 , C07C323/00 , C07C323/62 , C07C323/63 , C07D207/08 , C07D207/09 , C07D207/12 , C07D207/14 , C07D207/20 , C07D207/22 , C07D207/26 , C07D207/263 , C07D207/27 , C07D207/273 , C07D207/34 , C07D207/36 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D211/22 , C07D211/26 , C07D211/42 , C07D211/44 , C07D211/46 , C07D211/54 , C07D211/60 , C07D211/62 , C07D211/66 , C07D211/74 , C07D213/74 , C07D213/75 , C07D213/81 , C07D213/82 , C07D215/04 , C07D215/36 , C07D217/06 , C07D233/61 , C07D235/26 , C07D239/42 , C07D241/04 , C07D241/18 , C07D241/24 , C07D243/08 , C07D265/30 , C07D295/13 , C07D295/16 , C07D295/18 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D295/32 , C07D307/52 , C07D307/68 , C07D317/58 , C07D317/62 , C07D319/18 , C07D319/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D411/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/10 , C07D487/08 , C07D491/10 , A61K31/505 , A61K31/405 , C07C319/00 , C07D239/70 , C07D319/14
CPC分类号: C07D207/27 , C07C323/62 , C07D207/09 , C07D207/14 , C07D207/20 , C07D207/22 , C07D207/26 , C07D209/08 , C07D209/18 , C07D211/22 , C07D211/26 , C07D211/42 , C07D211/46 , C07D211/54 , C07D211/60 , C07D211/62 , C07D211/74 , C07D213/74 , C07D213/75 , C07D213/81 , C07D215/36 , C07D217/06 , C07D235/26 , C07D239/42 , C07D241/04 , C07D241/24 , C07D243/08 , C07D265/30 , C07D295/13 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D295/32 , C07D307/52 , C07D307/68 , C07D317/58 , C07D317/62 , C07D319/18 , C07D319/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D471/10 , C07D487/08 , C07D491/10 , C07C2101/02 , C07C2101/04 , C07C2101/08
摘要: The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
摘要翻译: 本发明涉及可用于治疗炎性和免疫疾病的新颖的肉桂酰胺化合物,包含这些化合物的药物组合物,以及抑制哺乳动物炎症或抑制免疫应答的方法。
-
4.Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds 审中-公开
标题翻译: 细胞粘附抑制抗炎和免疫抑制化合物公开(公告)号:US20050250768A1
公开(公告)日:2005-11-10
申请号:US10921965
申请日:2004-08-20
申请人: James Link , Gang Liu , ZhongHua Pei , Tom Geldern , Martin Winn , Zhili Xin , Steven Boyd , Gui-Dong Zhu , Jennifer Freeman , Indrani Gunawardana , Michael Staeger , Hwan-Soo Jae , John Lynch , Sheldon Wang
发明人: James Link , Gang Liu , ZhongHua Pei , Tom Geldern , Martin Winn , Zhili Xin , Steven Boyd , Gui-Dong Zhu , Jennifer Freeman , Indrani Gunawardana , Michael Staeger , Hwan-Soo Jae , John Lynch , Sheldon Wang
IPC分类号: A61K31/454 , A61K31/495 , A61K31/496 , A61K31/537 , A61K31/54 , C07C323/62 , C07D205/04 , C07D207/09 , C07D207/14 , C07D207/26 , C07D207/27 , C07D209/08 , C07D211/20 , C07D211/46 , C07D211/60 , C07D213/40 , C07D213/81 , C07D217/06 , C07D241/04 , C07D295/185 , C07D295/26 , C07D401/04 , C07D521/00
CPC分类号: C07D207/27 , A61K31/454 , A61K31/495 , A61K31/496 , A61K31/537 , A61K31/54 , C07C323/62 , C07C2601/02 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/08 , C07D211/20 , C07D211/46 , C07D211/60 , C07D213/40 , C07D213/81 , C07D217/06 , C07D231/12 , C07D233/56 , C07D241/04 , C07D249/08 , C07D295/185 , C07D295/26 , C07D401/04
摘要: The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
摘要翻译: 本发明涉及可用于治疗炎症和免疫疾病的新颖的肉桂酰胺化合物,含有这些化合物的药物组合物,以及抑制哺乳动物炎症或抑制免疫反应的方法。
-
公开(公告)号:US07169797B2
公开(公告)日:2007-01-30
申请号:US10771926
申请日:2004-02-04
申请人: Zhili Xin , Gang Liu , Zhonghua Pei , Bruce G. Szczepankiewicz , Michael D. Serby , Hongyu Zhao
发明人: Zhili Xin , Gang Liu , Zhonghua Pei , Bruce G. Szczepankiewicz , Michael D. Serby , Hongyu Zhao
IPC分类号: A61K31/445 , A61K31/41 , C07D211/32 , C07D285/12 , C07D271/06
CPC分类号: C07D413/04 , C07D261/18 , C07D413/12
摘要: The present invention is directed to compounds of formula (I), or a pharmaceutically suitable salt or prodrug thereof, which are useful for the selective inhibition of protein tyrosine phosphatase-1B (PTP1B), and are useful for the treatment of disorders caused by overexpressed or altered protein tyrosine phosphatase 1B.
摘要翻译: 本发明涉及可用于选择性抑制蛋白酪氨酸磷酸酶1B(PTP1B)的式(I)化合物或其药学上合适的盐或前药,并且可用于治疗由过表达 或改变的蛋白酪氨酸磷酸酶1B。
-
公开(公告)号:US06972340B2
公开(公告)日:2005-12-06
申请号:US09941471
申请日:2001-08-29
IPC分类号: A61P3/00 , A61P3/10 , C07C209/68 , C07C233/56 , C07C235/74 , C07C237/22 , C07C237/24 , C07C237/42 , C07C271/20 , C07C271/22 , C07C275/24 , C07C311/06 , C07C311/47 , C07C317/40 , C07C323/59 , C07D209/08 , C07D211/20 , C07D241/18 , C07D265/06 , C07D295/135 , C07D295/155 , C07D295/185 , C07D319/18 , C07C321/00 , C07C69/76 , C07C229/00 , C07C271/00
CPC分类号: C07C209/68 , C07C233/56 , C07C235/74 , C07C237/22 , C07C237/24 , C07C237/42 , C07C271/20 , C07C271/22 , C07C275/24 , C07C311/06 , C07C311/47 , C07C317/40 , C07C323/59 , C07C2601/04 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07D209/08 , C07D211/20 , C07D241/18 , C07D265/06 , C07D295/135 , C07D295/155 , C07D295/185 , C07D319/18
摘要: Compounds of formula (I) or therapeutically acceptable salts thereof, are selective protein tyrosine kinase-B (PTP1B) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of disorders using the compounds are disclosed.
摘要翻译: 式(I)化合物或其治疗上可接受的盐是选择性蛋白酪氨酸激酶-B(PTP1B)抑制剂。 公开了化合物的制备,含有该化合物的组合物和使用该化合物治疗病症。
-
公开(公告)号:US08202878B2
公开(公告)日:2012-06-19
申请号:US11947005
申请日:2007-11-29
申请人: Andrew J. Souers , Ju Gao , Todd M. Hansen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
发明人: Andrew J. Souers , Ju Gao , Todd M. Hansen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
IPC分类号: C07D487/04 , A61K31/519 , A61P3/04 , A61P3/10 , C07D231/20 , A61K31/4152
CPC分类号: C07D487/04 , C07C59/54 , C07C275/42 , C07D211/60 , C07D231/12 , C07D231/20 , C07D249/08 , C07D263/48 , C07D277/40 , C07D401/04 , C07D407/12 , C07D407/14 , C07D413/12 , C07D413/14
摘要: The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof, a pharmaceutical composition of formula (I), and related methods for treating or preventing metabolic diseases or conditions.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,式(I)的药物组合物以及用于治疗或预防代谢性疾病或病症的相关方法。
-
公开(公告)号:US20120238581A1
公开(公告)日:2012-09-20
申请号:US13484539
申请日:2012-05-31
申请人: Andrew J. Souers , Ju Gao , Todd M. Hasen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
发明人: Andrew J. Souers , Ju Gao , Todd M. Hasen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
IPC分类号: A61K31/415 , C07D405/14 , A61K31/4155 , C07D405/12 , C07D413/12 , A61K31/422 , C07D249/08 , A61K31/4196 , C07D413/14 , C07D403/12 , C07D277/42 , A61K31/426 , C07D401/12 , A61K31/4439 , C07D241/12 , A61K31/4965 , C07D487/04 , A61K31/519 , A61P3/10 , A61P3/04 , A61P3/06 , A61P3/00 , A61P1/16 , A61K31/454 , A61K31/455 , C07D231/20
CPC分类号: C07D487/04 , C07C59/54 , C07C275/42 , C07D211/60 , C07D231/12 , C07D231/20 , C07D249/08 , C07D263/48 , C07D277/40 , C07D401/04 , C07D407/12 , C07D407/14 , C07D413/12 , C07D413/14
摘要: Compounds of formula (I), or a pharmaceutically acceptable salt, prodrug, salt of a prodrug, or a combination thereof. Pharmaceutical compositions of formula (I) and related methods for treating or preventing metabolic diseases or conditions.
摘要翻译: 式(I)化合物或其药学上可接受的盐,前药,前药的盐或其组合。 式(I)的药物组合物和治疗或预防代谢疾病或病症的相关方法。
-
公开(公告)号:US08586594B2
公开(公告)日:2013-11-19
申请号:US13484539
申请日:2012-05-31
申请人: Andrew J. Souers , Ju Gao , Todd M. Hansen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
发明人: Andrew J. Souers , Ju Gao , Todd M. Hansen , Rajesh R. Iyengar , Philip R. Kym , Bo Liu , Zhonghua Pei , Vince S. Yeh , Gang Zhao , Zhili Xin
IPC分类号: A61K31/519 , A61P3/04 , A61P3/10 , A61K31/4152 , C07D487/04 , C07D231/20
CPC分类号: C07D487/04 , C07C59/54 , C07C275/42 , C07D211/60 , C07D231/12 , C07D231/20 , C07D249/08 , C07D263/48 , C07D277/40 , C07D401/04 , C07D407/12 , C07D407/14 , C07D413/12 , C07D413/14
摘要: Compounds of formula (I), or a pharmaceutically acceptable salt, prodrug, salt of a prodrug, or a combination thereof. Pharmaceutical compositions of formula (I) and related methods for treating or preventing metabolic diseases or conditions.
摘要翻译: 式(I)化合物或其药学上可接受的盐,前药,前药的盐或其组合。 式(I)的药物组合物和治疗或预防代谢疾病或病症的相关方法。
-
10.Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome 审中-公开
标题翻译: 新型乙酰辅酶A羧化酶(ACC)抑制剂及其在糖尿病,肥胖症和代谢综合征中的应用公开(公告)号:US20060178400A1
公开(公告)日:2006-08-10
申请号:US11268698
申请日:2005-11-07
申请人: Bruce Beutel , Heidi Camp , Richard Clark , Yu-Gui Gu , Todd Hansen , Robert Keyes , Qun Li , Gang Liu , Hing Sham , Xiaojun Wang , Moshe Weitzberg , Zhili Xin , Xiangdong Xu , Tianyuan Zhang
发明人: Bruce Beutel , Heidi Camp , Richard Clark , Yu-Gui Gu , Todd Hansen , Robert Keyes , Qun Li , Gang Liu , Hing Sham , Xiaojun Wang , Moshe Weitzberg , Zhili Xin , Xiangdong Xu , Tianyuan Zhang
IPC分类号: C07D211/68 , A61K31/445
CPC分类号: C07D211/68
摘要: The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
摘要翻译: 本发明涉及抑制乙酰辅酶A羧化酶(ACC)并可用于预防或治疗人类代谢综合征,II型糖尿病,肥胖症,动脉粥样硬化和心血管疾病的式(I)化合物。
-
-
-
-
-
-
-
-
-